Clinical Trials

NephroNet Investigators provide dedicated support for Proof of Concept through Phase IV studies. NephroNet can help you avoid costly clinical development failures by making better decisions in the protocol design to ensure endpoints are feasible and data analysis is meaningful. Our team of experts provides you with the required scientific, therapeutic, and regulatory expertise to design studies for new drugs for the treatment of chronic kidney disease.